27 certified Labor Condition Applications on file with the U.S. Department of Labor, FY2021–FY2026.
Since September 2025, DOL's Project Firewall opens H-1B investigations without waiting for a complaint. These checkpoints come from Havas Health, Inc.'s own public LCA filings (FY2024–FY2026) — the same records an investigator pulls first.
Level I is the entry-level prevailing-wage tier and the band DOL's Project Firewall reviews first for misclassification (senior duties filed at an entry-level wage). The national share is 17%.
Next end date: 2027-03-31. Employing an H-1B worker past the LCA end date without a new certified LCA is a strict-liability violation — the replacement LCA must be certified before the I-129 extension is filed.
Median offered wage is 5% above the DOL prevailing wage across 6 recent certified LCAs. Paying at the floor is lawful, but it invites the question of whether the wage level itself is right.
Each worksite needs its own 10-business-day LCA notice and a PAF record of that posting; a move to a new area of intended employment needs a new LCA before the worker starts there.
No additional recruitment or non-displacement attestations apply.
Public DOL disclosure data can lag actual filings by a quarter. Descriptive only — not legal advice.
Yes — Havas Health, Inc. sponsors H-1B workers, with 27 certified LCAs on file (FY2021–FY2026), including 1 in FY2026. The median certified salary is $139,999 (P25 $83,749, P75 $224,999). With a 32% transfer share, this employer actively accepts H-1B transfers. 100% of its certified filings meet or exceed the prevailing wage.
Havas Health, Inc. H-1B sponsorship at a glance, from public U.S. DOL LCA disclosure data (FY2021–FY2026).
Certified LCAs are a prerequisite to H-1B petitions, not visa approvals; one LCA can cover multiple workers. Descriptive only — not legal advice.
The shaded band is the middle half of certified salaries (P25–P75); the bar spans the lowest to highest certified salary.
Levels I–IV are DOL prevailing-wage experience tiers; 32% of filings are senior-level (III–IV).
| Fiscal year | Certified | Denied | Withdrawn | Total |
|---|---|---|---|---|
| FY2021 | 11 | 0 | 0 | 11 |
| FY2022 | 5 | 0 | 0 | 5 |
| FY2023 | 5 | 0 | 0 | 5 |
| FY2024 | 2 | 0 | 1 | 3 |
| FY2025 | 3 | 0 | 0 | 3 |
| FY2026 | 1 | 0 | 0 | 1 |
Case dispositions from the U.S. DOL OFLC disclosure files. Withdrawn are LCAs that were certified and later withdrawn by the employer; they still count toward Total.
| Job title | Salary | Level | Location | Filed | Status |
|---|---|---|---|---|---|
EVP, Global Creative Operations I-203-25273-347187 | $240,000/yr | III | New York, NY | Sep 30, 2025 | Certified |
VP, Account Group Supervisor I-200-25213-217075 | $135,000/yr | II | Waycross, GA | Aug 01, 2025 | Certified |
Finance Manager I-200-24290-411025 | $139,999/yr | I | New York, NY | Oct 16, 2024 | Certified |
Finance Manager I-200-24281-389840 | $139,921/yr$67/hr as filed | I | New York, NY | Oct 07, 2024 | Certified |
Scientific Associate I-200-24072-791352 | $79,999/yr | II | New York, NY | Mar 12, 2024 | Certified |
SVP, Medical Director I-200-24033-689722 | $269,999/yr | IV | New York, NY | Feb 02, 2024 | Certified |
EVP, Global Creative Operations I-203-23263-363893 | $219,999/yr | III | New York, NY | Sep 20, 2023 | Certified |
Financial Planning Analyst I-200-23146-057707 | $109,999/yr | II | New York, NY | May 26, 2023 | Certified |
Senior Medical Associate I-203-23034-749735 | $84,999/yr | II | New York, NY | Feb 03, 2023 | Certified |
Senior Art Director I-200-22277-509454 | $114,999/yr | I | New York, NY | Oct 04, 2022 | Certified |
SVP, Creative Director - Copy I-203-22201-364822 | $259,999/yr | IV | New York, NY | Jul 20, 2022 | Certified |
Director, Data Strategy I-203-22145-210680 | $144,199/yr | I | New York, NY | May 25, 2022 | Certified |
VP, Account Supervisor I-200-22110-090117 | $144,999/yr | I | New York, NY | Apr 20, 2022 | Certified |
EVP, Global Creative Operations I-203-21323-716328 | $219,999/yr | III | New York, NY | Nov 19, 2021 | Certified |
Director, Data Strategy I-203-21286-642296 | $139,999/yr | I | New York, NY | Oct 13, 2021 | Certified |
Medical Associate I-203-21127-295799 | $69,999/yr | II | New York, NY | May 07, 2021 | Certified |
SVP, Medical Director I-200-21083-171806 | $179,999/yr | II | New York, NY | Mar 24, 2021 | Certified |
Medical Associate I-203-21050-089332 | $69,999/yr | II | New York, NY | Feb 19, 2021 | Certified |
Creative I-203-20338-936691 | $71,999/yr | I | New York, NY | Dec 03, 2020 | Certified |
SVP, Creative Director I-203-20337-935008 | $259,999/yr | III | New York, NY | Dec 02, 2020 | Certified |
One row per LCA case (its latest version), from U.S. DOL OFLC disclosure data. Salaries are the offered wage, converted to a yearly figure. Certified LCAs are not visa approvals.
Worker positions by LCA filing purpose, summed across FY2021–FY2026 disclosure records.
Most active filing months: Dec and Oct — useful for timing transfer conversations.
Attestations from the employer's own LCA filings (Form ETA-9035), as disclosed by the U.S. DOL.
2 states · 2 cities
The same DOL data on this page is what every H-1B sponsor must track for each worker. ElevateStaffing.ai automates it end-to-end:
Get the private PAF / LCA gap check for your own filings — free, one business day — then let ElevateStaffing.ai keep every LCA, PAF, I-9 and I-983 deadline audit-ready.
Get my private gap check →